Why I Would Run to Immunotherapy: Laurie Adami in Conversation with CRI

Cancer Research Institute blog feature: A short interview piece in which Laurie speaks about immunotherapy's potential and her conviction that CAR-T's targeted approach represented a fundamental shift from the one-size-fits-all treatments she had previously endured.